Vimarsana
Biggest News Aggregation in the World

Maximum Tolerated Dose News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Maximum Tolerated Dose. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Maximum Tolerated Dose Today - Breaking & Trending Today

FDA targets cancer drugs to be less toxic, more cost effective - Vimarsana News

FDA targets cancer drugs to be less toxic, more cost effective

FDA urges drug companies to reassess cancer drug dosages for maximum impact and fewer side effects, following study on lung cancer drug

Genprex Expands Clinical Trial Sites for Acclaim-3 Clinical Study of Reqorsa® Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer - Vimarsana News

Genprex Expands Clinical Trial Sites for Acclaim-3 Clinical Study of Reqorsa® Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer

Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that through its collaboration agreement with a...

First in Human Dosed in Clinical Trial of ZMA001 for Treatment of Pulmonary Arterial Hypertension (PAH) - Vimarsana News

First in Human Dosed in Clinical Trial of ZMA001 for Treatment of Pulmonary Arterial Hypertension (PAH)

/PRNewswire/ -- Zymedi announced today that the first in human dosage of ZMA001, a monoclonal antibody being developed as a first-in-class treatment for...

As cancer treatment advances, patients and doctors push back against drugs' side effects - Vimarsana News

As cancer treatment advances, patients and doctors push back against drugs' side effects

A cancer patient says,

Taysha Gene Therapies Announces First Pediatric Patient Dosed with TSHA-102 in REVEAL Phase 1/2 Pediatric Trial in Rett Syndrome - Vimarsana News

Taysha Gene Therapies Announces First Pediatric Patient Dosed with TSHA-102 in REVEAL Phase 1/2 Pediatric Trial in Rett Syndrome

Initiation of REVEAL pediatric trial in the U.S.broadens the clinical evaluation of TSHA-102 to female patients 5-8 years old with stage three Ret...